Discovery of imidazopyridine and imidazopyridazine inhibitors of PI3K

被引:0
|
作者
Han, Wooseok [1 ]
Pecchi, Sabina [1 ]
Burger, Matthew [1 ]
Lan, Jiong [1 ]
Smith, Aaron [1 ]
Knapp, Mark [1 ]
Huh, Kay [1 ]
De Menezes, Daniel Lopes [1 ]
Jansen, Johanna [1 ]
Merritt, Hanne [1 ]
Kaufman, Susan [1 ]
Voliva, Charles [1 ]
机构
[1] Novartis Inst Biomed Res, Emeryville, CA 94608 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
42-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [41] The development of inhibitors of PI3K and Akt
    Dennis, PA
    ANNALS OF ONCOLOGY, 2006, 17 : 24 - 24
  • [42] PI3K inhibitors in haematological malignancies
    Brown, Jennifer R.
    Danilov, Alexey V.
    LaCasce, Ann S.
    Davids, Matthew S.
    LANCET ONCOLOGY, 2022, 23 (08): : E364 - E364
  • [43] Clinical development of inhibitors of the PI3K
    Saura Manich, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [44] Predictive and pharmacodynamic (PD) markers of PI3K pathway inhibitors: focus on PI3K, AKT and mTOR inhibitors
    Tabernero, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S6 - S6
  • [45] Discovery of an irreversible PI3Kα-specific Inhibitor
    Qiao, Lixin
    Nacht, Mariana
    Sheets, Michael P.
    St Martin, Thia
    Labenski, Matthew
    Mazdiyasni, Hormoz
    Zhu, Zhendong
    Chaturvedi, Prasoon
    Bhavsar, Deepa
    Niu, Deqiang
    Westlin, William
    Petter, Russell
    Singh, Juswinder
    CANCER RESEARCH, 2011, 71
  • [46] PI3K signalling: the path to discovery and understanding
    Vanhaesebroeck, Bart
    Stephens, Len
    Hawkins, Phillip
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2012, 13 (03) : 195 - 203
  • [47] PI3K signalling: the path to discovery and understanding
    Bart Vanhaesebroeck
    Len Stephens
    Phillip Hawkins
    Nature Reviews Molecular Cell Biology, 2012, 13 : 195 - 203
  • [48] Discovery of Novel Azaindoles as Potent and Selective PI3Kδ Inhibitors for Treatment of Multiple Sclerosis
    Yu, Mengyao
    Wang, Xian
    Tang, Yongmei
    Wang, Longling
    Hu, Xueping
    Weng, Qinjie
    Wang, Jiajia
    Cui, Sunliang
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 9628 - 9644
  • [49] Discovery of benzoxazepin PI3K inhibitors and optimization of p110-alpha selectivity
    Ndubaku, Chudi O.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [50] Discovery of Novel PI3Kδ Inhibitors Based on the p110δ Crystal Structure
    Jia, Wenqing
    Luo, Shuyu
    Zhao, Wennan
    Xu, Weiren
    Zhong, Yuxu
    Kong, Dexin
    MOLECULES, 2022, 27 (19):